Company page

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. (ticker: RIGL) is a public company based in the United States with a market capitalization of approximately $536.7 million. The company focuses on developing innovative treatments for various diseases, leveraging its expertise in drug discovery and development. Rigel is committed to advancing its pipeline of therapies to address unmet medical needs.